Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence

Table 1 Study population characteristics

Study	Age range	Mean age	Sex	Race	Proportion of sample with schizophrenia and bipolar disorder	Antipsychotic use
Kilbourne, 2011 [22]	18-65	55	9% female	24% black,	100% Schizophrenia	100%
Kilbourne, 2011 [22]	18-65	55	9% female	76% other	100% Schizophrenia	100%
Morrato, 2008 [25]	All ages	Not reported	50% female	58% white,	100% Schizophrenia¹	100%
Morrato, 2008 [25]	All ages	Not reported	50% female	42% other	100% Schizophrenia¹	100%
Moeller, 2011 [26]	18-64	44	49% female	83% white,	100% Schizophrenia	100%
Moeller, 2011 [26]	18-64	44	49% female	17% other	100% Schizophrenia	100%
Morrato, 2009 [27]	20-88	Not reported	50% female	Not reported	3.4% Schizophrenia, 49.3% Mood disorders, including bipolar disorder	100%
Kaplowitz, 2006 [30]	20+	67	4% female	Not reported	51.0% Mood disorders, including bipolar disorder	Not reported
Weissman, 2006 [31]	18-65	50	6% female	Not reported	100% Schizophrenia	100%
Barnett, 2010 [32]	21-63	45	59% female	43% white,	Not reported	100%
				14% black,
				43% other
Kilbourne, 2008 [34]	18+	67	3% female	8% black,	100% Schizophrenia, bipolar disorder, or other psychosis²	Not reported
Kilbourne, 2008 [34]	18+	67	3% female	92% other	100% Schizophrenia, bipolar disorder, or other psychosis²	Not reported
Folsom, 2002 [35]	45+	51	47% female	70% white,	100% Schizophrenia³	Not reported
				15% black,
				15% other
Dickerson 2003 [38]	18-65	44	53% female	56% white,	50% Schizophrenia, 25% Bipolar disorder	Not reported
				35.5% black,
				8.5% other

¹The full study population also included individuals with other or no mental health diagnoses, but all screening measures abstracted for this review were assessed in the study population with schizophrenia only.
²The full study population also included individuals with depression and individuals with no psychiatric diagnoses, but all screening measures abstracted for this review were assessed in the study population with schizophrenia, bipolar disorder, or other psychoses only.
³The full study population also included individuals with depression, but all screening measures abstracted for this review were assessed in the study population with schizophrenia only.